Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases. - Dhaenens, Britt A E; Heimann, Günter; Bakker, Annette; Nievo, Marco; Ferner, Rosalie E; Evans, D Gareth; Wolkenstein, Pierre; Leubner, Jonas; Potratz, Cornelia; Carton, Charlotte; Iloeje, Uchenna; Kirk, George; et al. (Neuro-Oncology Practice, 2024)